As of April 16, 2025, Sage Therapeutics (SAGE) has a market cap of $0.46 billion USD. According to our data, Sage Therapeutics is ranked No.6068 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.46 B |
37.34%
|
Dec 31, 2024 | $0.33 B |
-74.94%
|
Dec 29, 2023 | $1.33 B |
-43.18%
|
Dec 30, 2022 | $2.33 B |
-10.34%
|
Dec 31, 2021 | $2.60 B |
-50.83%
|
Dec 31, 2020 | $5.29 B |
19.84%
|
Dec 31, 2019 | $4.42 B |
-24.64%
|
Dec 31, 2018 | $5.86 B |
-41.84%
|
Dec 29, 2017 | $10.08 B |
222.58%
|
Dec 30, 2016 | $3.12 B |
-12.42%
|
Dec 31, 2015 | $3.57 B |
59.29%
|
Dec 31, 2014 | $2.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$218.28 B |
1.163 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$127.25 B |
3.672 B
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$72.32 B |
0.003 M
|
![]() UK
|
Market Cap | = | SAGE Stock Price | * | SAGE Shares Outstanding |
= | $7.42 | * | 61.48 M | |
= | $0.46 B |